Literature DB >> 21864067

Brain 11: what's new in stroke research?

Midori A Yenari1, Jong Eun Lee.   

Abstract

The International Society for Cerebral Blood Flow and Metabolism promotes research centered on furthering the understanding of neurological conditions that result from ischemia and related injuries. This previous meeting (Brain 11) focused on state-of-the-art research, which shed light on the pathophysiology of these conditions as they pertained to the cerebral vasculature - including the BBB - and angiogenesis, immune mechanisms, regeneration and repair following such insults. The meeting also covered a variety of potential therapeutic strategies ranging from cell-based therapy, induced tolerance and the targeting of specific immune or cell death pathways. In addition, there was a focus on how the peripheral circulation contributes to such types of brain injury.

Entities:  

Mesh:

Year:  2011        PMID: 21864067      PMCID: PMC6892589          DOI: 10.1586/ern.11.107

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  10 in total

Review 1.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

2.  Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms.

Authors:  Masaaki Hokari; Satoshi Kuroda; Hideo Shichinohe; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki
Journal:  J Neurosci Res       Date:  2008-04       Impact factor: 4.164

3.  Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI.

Authors:  Raphael Guzman; Nobuko Uchida; Tonya M Bliss; Dongping He; Karen K Christopherson; David Stellwagen; Alexandra Capela; Joan Greve; Robert C Malenka; Michael E Moseley; Theo D Palmer; Gary K Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

Review 4.  Neural stem cells: involvement in adult neurogenesis and CNS repair.

Authors:  Hideyuki Okano; Kazunobu Sawamoto
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

5.  Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

Authors:  Robert D Bell; Ethan A Winkler; Abhay P Sagare; Itender Singh; Barb LaRue; Rashid Deane; Berislav V Zlokovic
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

Review 6.  Multiple roles of metalloproteinases in neurological disorders.

Authors:  Yi Yang; Jeff W Hill; Gary A Rosenberg
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 7.  Stem cells and stroke: opportunities, challenges and strategies.

Authors:  Terry C Burns; Gary K Steinberg
Journal:  Expert Opin Biol Ther       Date:  2011-02-16       Impact factor: 4.388

8.  CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.

Authors:  Eunhee Kim; Aaron T Tolhurst; Lu Ye Qin; Xin-Yuan Chen; Maria Febbraio; Sunghee Cho
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

9.  Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.

Authors:  Mélanie Lalancette-Hébert; Geneviève Gowing; Alain Simard; Yuan Cheng Weng; Jasna Kriz
Journal:  J Neurosci       Date:  2007-03-07       Impact factor: 6.167

10.  Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

Authors:  Wolfgang J Streit; Heiko Braak; Qing-Shan Xue; Ingo Bechmann
Journal:  Acta Neuropathol       Date:  2009-06-10       Impact factor: 17.088

  10 in total
  1 in total

1.  Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.

Authors:  Gozde Colak; Gail V W Johnson
Journal:  Neurobiol Dis       Date:  2011-12-14       Impact factor: 5.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.